Products for Research Use Only
RegisterLogin

MTI-31

CAT: 1410-M12239-01Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M12239-01Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MTI-31 (LXI-15029, mTOR inhibitor-31) is a novel potent, selective mTORC1/mTORC2 inhibitor with Kd of 0.2 nM (mTOR) .
CAS Number
1567915-38-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
474.565
Molecular Formula
C26H30N6O3
Notes
Research use only, not for human use.
Receptor
MTOR

Chemical Information

Mti-31

mTORC 1/2 Inhibitor LXI-15029 is an orally bioavailable inhibitor of raptor-mammalian target of rapamycin (mTOR) complex 1 (mTOR complex 1; mTORC1) and rictor-mTOR complex 2 (mTOR complex 2; mTORC2), with potential antineoplastic activity. Upon oral administration, mTORC1/2 inhibitor LXI-15029 binds to the kinase domain of mTOR and inhibits both mTORC1 and mTORC2, in an ATP-competitive manner. This inhibits mTOR-mediated signaling and leads to both an induction of apoptosis and a decrease in the proliferation of mTORC1/2-expressing tumor cells. mTOR is a serine/threonine kinase that is upregulated in certain tumor cell types. It plays an important role in the PI3K/Akt/mTOR signaling pathway, which is often deregulated in cancer cells and promotes cell growth, survival, and resistance to chemotherapy and radiotherapy.

CAS Number1567915-38-1
PubChem CID118591386
IUPAC NameN-methyl-3-[2-[(3S)-3-methylmorpholin-4-yl]-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)pyrido[2,3-d]pyrimidin-7-yl]benzamide
Molecular FormulaC26H30N6O3
Molecular Weight474.6
XLogP3
Topological Polar Surface Area92.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Heavy Atom Count35
Formal Charge0
Complexity745
SMILES
C[C@H]1COCCN1C2=NC3=C(C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)C(=N2)N5C6CCC5COC6
InChI
InChI=1S/C26H30N6O3/c1-16-13-34-11-10-31(16)26-29-23-21(24(30-26)32-19-6-7-20(32)15-35-14-19)8-9-22(28-23)17-4-3-5-18(12-17)25(33)27-2/h3-5,8-9,12,16,19-20H,6-7,10-11,13-15H2,1-2H3,(H,27,33)/t16-,19?,20?/m0/s1
InChIKey
LVPBYQVQBZLDAU-DZIBYMRMSA-N
Chemical Structure
2D Structure
2D structure of Mti-31
CAS: 1567915-38-1
CID: 118591386
Formula: C26H30N6O3
MW: 474.6
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight474.6
XLogP33
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass474.23793884
Monoisotopic Mass474.23793884
Topological Polar Surface Area92.7 Ų
Heavy Atom Count35
Formal Charge0
Complexity745
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
M28773-01HCV-IN-31
M13541-01KUNB 31
M13254-01AZ-31
M10118LM11A-31
M15774-01STF-31
M21735-0131-Norlanostenol
M14849-01FLLL-31
M11278JAK1-IN-31
M28353-01PACMA 31
M41075[Cys (Acm) 20,31]-EGF (20-31)

Alternative Products

CatalogName
BA8712-1MTI-31
I8442-40JInterleukin 31 (IL-31)
228236Interleukin-31 (IL-31)
832126MIC-FR-PK-MTI-451-OR AO LOTO
832260MIC-NL-PK-MTI-405-OR AO LOTO
832225MIC-NL-MTI-I-OR-20 AO LOTO
832235MIC-NL-PK-MTI-I-OR AO LOTO
832272MIC-NL-PK-MTI-451-OR AO LOTO
832093MIC-FR-MTI-GPI-OR-20 AO LOTO
832089MIC-FR-PK-MTI-I-OR AO LOTO

Popular Products